Respirology Search
Respirology Respirology
Most Read Articles
Atopic dermatitis tied to active, passive smoking
12 Nov 2017
Active and passive smoking are associated with atopic dermatitis, a new study from Korea reveals.
New targeted therapy for lung cancer broadens options for second-line therapy
Pank Jit Sin, 09 Aug 2018

Atezolizumab (Tecentriq®, Roche) a programmed death-ligand 1 (PD-L1) inhibitor, is now approved for the treatment of patients with metastatic non-small cell lung cancer who have diseases progression during or following a platinum-containing therapy.

Poor asthma control, med compliance common in schoolkids
Pearl Toh, 19 Apr 2017
Almost half of secondary school children who had been diagnosed with asthma had suboptimal asthma control, yet over half of those surveyed did not use their inhalers as prescribed, a recent study found.

Podcast: Interview with Associate Prof Marysia Stella T. Recto: The role of bilastine in the treatment of allergic rhinitis and urticaria

23 Jul 2018
Podcast: Interview with Associate Prof Marysia Stella T. Recto: The role of bilastine in the treatment of allergic rhinitis  and urticaria
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Atopic dermatitis tied to active, passive smoking
12 Nov 2017
Active and passive smoking are associated with atopic dermatitis, a new study from Korea reveals.
New targeted therapy for lung cancer broadens options for second-line therapy
Pank Jit Sin, 09 Aug 2018

Atezolizumab (Tecentriq®, Roche) a programmed death-ligand 1 (PD-L1) inhibitor, is now approved for the treatment of patients with metastatic non-small cell lung cancer who have diseases progression during or following a platinum-containing therapy.

Poor asthma control, med compliance common in schoolkids
Pearl Toh, 19 Apr 2017
Almost half of secondary school children who had been diagnosed with asthma had suboptimal asthma control, yet over half of those surveyed did not use their inhalers as prescribed, a recent study found.